Clinical Trial: Molecular Identification of Major Allergens of Artemisia ordosica Pollen, Characterization of Clinical Sensitization Profiles, and Its Application in Diagnosis and Immunotherapeutic Preparations (China)

Posted On: 2026-08-17

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Molecular Identification of Major Allergens of Artemisia ordosica Pollen, Characterization of Clinical Sensitization Profiles, and Its Application in Diagnosis and Immunotherapeutic Preparations'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130077

Registration Time: 2026/08/14

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Xi 'an Jiaotong University Yulin Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334127

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Molecular Identification of Major Allergens of Artemisia ordosica Pollen, Characterization of Clinical Sensitization Profiles, and Its Application in Diagnosis and Immunotherapeutic Preparations (China)